Middle East Respiratory Syndrome Corona Virus (MERS CoV): The next steps.
Identifieur interne : 000639 ( PubMed/Curation ); précédent : 000638; suivant : 000640Middle East Respiratory Syndrome Corona Virus (MERS CoV): The next steps.
Auteurs : Iype Joseph [Inde]Source :
- Journal of public health policy [ 1745-655X ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- epidemiology : Coronavirus Infections, Middle East.
- prevention & control : Coronavirus Infections, Disease Outbreaks.
- Humans, Middle East Respiratory Syndrome Coronavirus, Population Surveillance.
Abstract
Developing countries are at risk of importing Middle East Respiratory Syndrome Corona Virus (MERS CoV) from the Middle East. Hospitals in the Middle East currently reporting the disease are staffed by immigrants. In the current hot spots for MERS CoV a sizeable portion of the population is from other countries, but many of these countries have yet to detect any importation of MERS CoV. To assess the disease transmission in these countries, supplemental surveillance strategies are urgently needed beyond the currently recommended measures. A few strategies to address the situation are: (i) improving preparedness with enhanced surveillance in particular regions; (ii) targeting certain sentinel groups for surveillance in hot spots; and (iii) limited use of serosurveillance. Recovered, immune patients can be employed to give patient care during outbreaks.
DOI: 10.1057/jphp.2015.9
PubMed: 25811387
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000639
Links to Exploration step
pubmed:25811387Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Middle East Respiratory Syndrome Corona Virus (MERS CoV): The next steps.</title><author><name sortKey="Joseph, Iype" sort="Joseph, Iype" uniqKey="Joseph I" first="Iype" last="Joseph">Iype Joseph</name><affiliation wicri:level="1"><nlm:affiliation>Rajiv Gandhi Centre for Biotechnology, Pathogen Biology Group, Thycaud Post, Poojappura, Trivandrum, Kerala 695014, India. E-mails: iypejoseph@rgcb.res.in; driype@yahoo.com.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Rajiv Gandhi Centre for Biotechnology, Pathogen Biology Group, Thycaud Post, Poojappura, Trivandrum, Kerala 695014</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25811387</idno><idno type="pmid">25811387</idno><idno type="doi">10.1057/jphp.2015.9</idno><idno type="wicri:Area/PubMed/Corpus">000639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000639</idno><idno type="wicri:Area/PubMed/Curation">000639</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000639</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Middle East Respiratory Syndrome Corona Virus (MERS CoV): The next steps.</title><author><name sortKey="Joseph, Iype" sort="Joseph, Iype" uniqKey="Joseph I" first="Iype" last="Joseph">Iype Joseph</name><affiliation wicri:level="1"><nlm:affiliation>Rajiv Gandhi Centre for Biotechnology, Pathogen Biology Group, Thycaud Post, Poojappura, Trivandrum, Kerala 695014, India. E-mails: iypejoseph@rgcb.res.in; driype@yahoo.com.</nlm:affiliation><country xml:lang="fr">Inde</country><wicri:regionArea>Rajiv Gandhi Centre for Biotechnology, Pathogen Biology Group, Thycaud Post, Poojappura, Trivandrum, Kerala 695014</wicri:regionArea></affiliation></author></analytic><series><title level="j">Journal of public health policy</title><idno type="eISSN">1745-655X</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Disease Outbreaks (prevention & control)</term><term>Humans</term><term>Middle East (epidemiology)</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Population Surveillance</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Flambées de maladies ()</term><term>Humains</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (épidémiologie)</term><term>Moyen Orient (épidémiologie)</term><term>Surveillance de la population</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Middle East</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Disease Outbreaks</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Moyen Orient</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Population Surveillance</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Flambées de maladies</term><term>Humains</term><term>Infections à coronavirus</term><term>Surveillance de la population</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Developing countries are at risk of importing Middle East Respiratory Syndrome Corona Virus (MERS CoV) from the Middle East. Hospitals in the Middle East currently reporting the disease are staffed by immigrants. In the current hot spots for MERS CoV a sizeable portion of the population is from other countries, but many of these countries have yet to detect any importation of MERS CoV. To assess the disease transmission in these countries, supplemental surveillance strategies are urgently needed beyond the currently recommended measures. A few strategies to address the situation are: (i) improving preparedness with enhanced surveillance in particular regions; (ii) targeting certain sentinel groups for surveillance in hot spots; and (iii) limited use of serosurveillance. Recovered, immune patients can be employed to give patient care during outbreaks. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25811387</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-655X</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>3</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of public health policy</Title><ISOAbbreviation>J Public Health Policy</ISOAbbreviation></Journal><ArticleTitle>Middle East Respiratory Syndrome Corona Virus (MERS CoV): The next steps.</ArticleTitle><Pagination><MedlinePgn>318-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1057/jphp.2015.9</ELocationID><Abstract><AbstractText>Developing countries are at risk of importing Middle East Respiratory Syndrome Corona Virus (MERS CoV) from the Middle East. Hospitals in the Middle East currently reporting the disease are staffed by immigrants. In the current hot spots for MERS CoV a sizeable portion of the population is from other countries, but many of these countries have yet to detect any importation of MERS CoV. To assess the disease transmission in these countries, supplemental surveillance strategies are urgently needed beyond the currently recommended measures. A few strategies to address the situation are: (i) improving preparedness with enhanced surveillance in particular regions; (ii) targeting certain sentinel groups for surveillance in hot spots; and (iii) limited use of serosurveillance. Recovered, immune patients can be employed to give patient care during outbreaks. </AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>Iype</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rajiv Gandhi Centre for Biotechnology, Pathogen Biology Group, Thycaud Post, Poojappura, Trivandrum, Kerala 695014, India. E-mails: iypejoseph@rgcb.res.in; driype@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Public Health Policy</MedlineTA><NlmUniqueID>8006508</NlmUniqueID><ISSNLinking>0197-5897</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Public Health Policy. 2015 Aug;36(3):283-6</RefSource><PMID Version="1">25925086</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008877" MajorTopicYN="N">Middle East</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065207" MajorTopicYN="Y">Middle East Respiratory Syndrome Coronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25811387</ArticleId><ArticleId IdType="pii">jphp20159</ArticleId><ArticleId IdType="doi">10.1057/jphp.2015.9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367 (19):1814-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pathol. 2015 Jan;235(2):175-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25294366</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2013 Oct;19(10):1697-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24050621</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hosp Infect. 2014 Aug;87(4):185-93</Citation><ArticleIdList><ArticleId IdType="pubmed">24996515</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosecur Bioterror. 2011 Jun;9(2):89-115</Citation><ArticleIdList><ArticleId IdType="pubmed">21612363</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Apr 15;44(8):1017-25</Citation><ArticleIdList><ArticleId IdType="pubmed">17366443</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Curr. 2013 Jul 17;5:null</Citation><ArticleIdList><ArticleId IdType="pubmed">23884087</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 Aug 29;369(9):884-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23923992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2013 May;13(5):394-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23755396</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2014 Feb;14 (2):100</Citation><ArticleIdList><ArticleId IdType="pubmed">24457168</ArticleId></ArticleIdList></Reference><Reference><Citation>Biosci Trends. 2013 Dec;7(6):290-3</Citation><ArticleIdList><ArticleId IdType="pubmed">24390368</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2014 Dec;42(12 ):1261-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25465253</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2013 Dec 12;18(50):20662</Citation><ArticleIdList><ArticleId IdType="pubmed">24342516</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000639 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000639 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:25811387
|texte= Middle East Respiratory Syndrome Corona Virus (MERS CoV): The next steps.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25811387" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a CovidV1
| This area was generated with Dilib version V0.6.33. |  |